Her breakthrough came from modifying mRNA nucleosides, such as pseudouridine, to reduce immunogenicity, enabling therapeutic and vaccine applications, a gradual, evidence-driven process rather than a sudden insight.

She highlights the essential support from family and collaborators, plus a Stoic focus on controllable factors, as critical to her progress.

Early-life curiosity and optimism, coupled with experiences battling cancer, reinforced her dedication to scientific pursuit and resilience under pressure.

Katalin Karikó, the 2023 Nobel Laureate in Physiology or Medicine, persevered for four decades in mRNA research, rising from a challenging Hungarian upbringing to global scientific prominence.

Her view of success centers on staying true to curiosity and personal integrity, rather than external accolades, and she remains active in conferences and mentorship.

Her broader message to aspiring scientists is to focus on scientific progress over careers or fame, staying open to new discoveries as the field evolves.

Her career faced repeated setbacks, including demotion and funding difficulties at the University of Pennsylvania, yet she remained optimistic by concentrating on what she could change and valuing persistence over external validation.

She rejects the idea of a single eureka moment, emphasizing long experiments to establish causality and the critical role of rigorous controls, such as proving pseudouridine’s effect beyond contaminants.

She explains the mechanics: modified RNA evades degradation by immune sensors in endosomes, enabling efficient protein translation and underpinning modern mRNA therapies and vaccines.